Reveleer to Demonstrate AI’s Transformative Impact on Value-Based Care at ViVE 2025

Leading value-based care platform accelerates into 2025 with strong momentum and plans for continued growth.

GLENDALE, Calif., Feb. 13, 2025 /PRNewswire/ — Reveleer, the leading value-based care enablement platform, will demonstrate AI-powered, intelligent automation solutions at ViVE, taking place February 16-19, 2025.

Featuring its Evidence Validation Engine (EVE™), Reveleer’s platform unifies and transforms structured, semi-structured, and unstructured clinical data — such as notes, test results, and medical histories — into clinical insights. These insights intelligently automate and power workflows to improve efficiency, enhance patient care, and strengthen financial performance. By making sense of vast amounts of healthcare data, we help clinicians and health plans work together more effectively, keeping the focus where it belongs – delivering better patient care.

Reveleer solidified its leadership in artificial intelligence healthcare solutions in 2024 hitting significant milestones, including:

  • Processed 1.1 billion pages of clinical data helping payers and providers manage vast amounts of information with unparalleled efficiency.
  • Achieved an industry-leading accuracy rate of 99% through our proprietary AI-scoring model.
  • Facilitated the validation of over 2.5 million diagnoses showcasing its ability to use artificial intelligence to enhance clinical accuracy and scale.
  • Onboarded 25 new customers expanding its reach and impact across the healthcare ecosystem.

“Reveleer is transforming how payers and providers harness clinical data to drive better decisions and outcomes,” said Jay Ackerman, CEO of Reveleer. “Our AI-powered technology aggregates and analyzes patient data across care settings, delivering a complete, transparent view of the patient’s journey. More than just insights, our solutions take the next best action to intelligently automate and optimize value-based care workflows — driving efficiency, accuracy, and measurable ROI.”

ViVE attendees will have the opportunity to experience live demos of Reveleer’s risk, quality, and clinical intelligence solutions, and learn about how our intelligent automation optimizes workflows across the risk continuum.

To learn more about Reveleer, stop by booth 538 at ViVE 2025 or visit reveleer.com.

About Reveleer
As the industry’s pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by provider and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at Reveleer.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-to-demonstrate-ais-transformative-impact-on-value-based-care-at-vive-2025-302375669.html

SOURCE Reveleer

Staff

Recent Posts

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

17 hours ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

23 hours ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

23 hours ago

Extendicare Announces December 2025 Dividend of C$0.042 per Share

MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…

23 hours ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…

23 hours ago